Analyst Price Targets — GBIO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 16, 2025 2:09 pm | — | Wedbush | $5.50 | $5.33 | TheFly | Generation Bio price target lowered to $5.50 from $7 at Wedbush |
| December 16, 2025 10:09 am | — | Jefferies | $5.00 | $5.40 | TheFly | Generation Bio downgraded to Hold from Buy at Jefferies |
Latest News for GBIO
INCHEON, Korea--(BUSINESS WIRE)-- #Biosimilar--Samsung Bioepis Co., Ltd. and Epis NexLab Co., Ltd., a sister company to Samsung Bioepis under Samsung Epis Holdings (KRX: 0126Z0), today announced a research collaboration and license agreement with G2GBIO, a company specializing in the development of sustained-release formulations, to develop novel assets based on G2GBIO's proprietary microsphere technology. Under the…
Generation Bio Co. (NASDAQ: GBIO - Get Free Report) has earned an average rating of "Hold" from the seven research firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating on the company. The
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for GBIO.
U.S. House Trading
No House trades found for GBIO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.